Edition:
India

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

537.35INR
6 May 2016
Change (% chg)

Rs-4.45 (-0.82%)
Prev Close
Rs541.80
Open
Rs540.00
Day's High
Rs542.75
Day's Low
Rs535.10
Volume
511,789
Avg. Vol
1,926,716
52-wk High
Rs745.00
52-wk Low
Rs494.55

CIPL.NS

Chart for CIPL.NS

About

Cipla Limited is a pharmaceutical company. The Company's business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company offers APIs, formulations and veterinary products. As of March 31, 2015, the Company offered its services across five continents across the world. It offers... (more)

Overall

Beta: 0.49
Market Cap(Mil.): Rs435,312.81
Shares Outstanding(Mil.): 803.46
Dividend: 2.00
Yield (%): 0.37

Financials

  CIPL.NS Industry Sector
P/E (TTM): 25.96 33.21 39.76
EPS (TTM): 20.87 -- --
ROI: -- 12.89 12.39
ROE: -- 13.58 13.27
Search Stocks

BUZZ-India Cipla falls ahead of earnings; net income may miss estimates

** The pharmaceutical major will report Dec-qtr earnings later in the day

10 Feb 2016

Baxalta-Coherus Enbrel biosimilar succeeds in late-stage study

Baxalta Inc and Coherus Biosciences Inc said their experimental biosimilar of Amgen Inc's arthritis drug Enbrel met the main goal in a late-stage study.

11 Jan 2016

UPDATE 1-Baxalta-Coherus Enbrel biosimilar succeeds in late-stage study

Jan 11 Baxalta Inc and Coherus Biosciences Inc said their experimental biosimilar of Amgen Inc's arthritis drug Enbrel met the main goal in a late-stage study.

11 Jan 2016

Earnings vs. Estimates

Search Stocks